Related Experiment Videos
[Haemophilus influenzae meningitis in Austria: 1990-1992 incidence]
Insights
Haemophilus influenzae meningitis incidence in Austrian children under five remained high despite the 1992 introduction of the Hib vaccine. New strategies are needed to improve vaccination rates and reduce disease burden.
Area of Science:
- Pediatric infectious diseases
- Epidemiology
- Vaccinology
Context:
- High incidence of Haemophilus influenzae meningitis in children under 5 years in Austria between 1990-1992.
- Lower incidence rates observed in other age groups.
- Introduction of the Haemophilus influenzae type b (Hib) vaccine in 1992 for children under 5.
Purpose:
- To analyze the incidence of Haemophilus influenzae meningitis in children under 5 years in Austria.
- To evaluate the initial impact of Hib vaccination on meningitis incidence.
- To identify the need for improved immunization strategies.
Summary:
- Incidence rates of Haemophilus influenzae meningitis in Austrian children under 5 were 9.5/10(5) in 1990, 12.4/10(5) in 1991, and 10.4/10(5) in 1992.
- Despite the 1992 recommendation and registration of the Hib vaccine for this age group, no impact on meningitis incidence was observed.
- Incidence in other age groups remained significantly lower, below 1/10(5).
Impact:
- The study highlights a lack of observed impact of the Hib vaccine on Haemophilus influenzae meningitis rates in young Austrian children shortly after its introduction.
- It underscores the critical need for developing and implementing novel strategies to enhance vaccine uptake and effectiveness.
- Further research is required to understand barriers to immunization and to optimize public health interventions for preventing childhood meningitis.
Abstract:
The incidence of Haemophilus influenzae meningitis in children aged less than 5 years in Austria was 9.5/10(5) (n = 42) in the year 1990, 12.4/10(5) (n = 56) in 1991 and 10.4/10(5) (n = 48) in 1992. In each of the other 5-year age groups the incidence was lower than 1/10(5). In 1992 Hib vaccine was registered and recommended for children below 5 years of age. So far no impact of immunisation has been observed on the incidence of meningitis. A new strategy must be found to improve the implementation of immunisation.